Website Header with Language Selector and Dropdowns

Doripenem is a broad-spectrum carbapenem antibiotic used to treat serious bacterial infections, including intra-abdominal infections and pneumonia. It works by inhibiting bacterial cell wall synthesis, effectively killing bacteria. It is used in a hospital setting for severe infections.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Doripenem and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Doripenem impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Doripenem-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.

CAT No: CL-DPNM-01
CAS No: 148016-81-3
Mol Wt: 420.5
Mol F: C15H24N4O6S2
Inv Status:Custom Synthesis
CAT No: CL-DPNM-02
CAS No: 364622-82-2
Mol Wt: 420.5 : 18.0
Mol F: C15H24N4O6S2 : H2O
Inv Status:Custom Synthesis
CAT No: CL-DPNM-03
CAS No: NA
Mol Wt: 841
Mol F: C30H48N8O12S4
Inv Status:Custom Synthesis
CAT No: CL-DPNM-04
CAS No: NA
Mol Wt: 475.6
Mol F: C18H29N5O6S2
Inv Status:Custom Synthesis
CAT No: CL-DPNM-05
CAS No: 1973411-88-9
Mol Wt: 476.6
Mol F: C19H32N4O6S2
Inv Status:Custom Synthesis
CAT No: CL-DPNM-06
CAS No: 2220995-13-9
Mol Wt: 438.5
Mol F: C15H26N4O7S2
Inv Status:Custom Synthesis
Address(India):

Plot No. A-737/2, TTC Industrial area,
MIDC, Kopar Khairne, Navi Mumbai, INDIA, 400710

           
Address(Bangladesh):

House No. - 12, Road No. - 17, Nikunja -2,
Khilkhet, Dhaka-1230, Bangladesh.

Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.